Profiel
Rick Kendall formerly worked at PYC Therapeutics Ltd., as Non-Executive Director in 2017, Amgen Australia Pty Ltd., as Executive Director-Oncology Research, and Kite Pharma, Inc., as Vice President-Research.
Eerdere bekende functies van Rick Kendall
| Bedrijven | Functie | Einde |
|---|---|---|
| PYC THERAPEUTICS LIMITED | Directeur/Bestuurslid | 23-10-2017 |
| Amgen Australia Pty Ltd. | Corporate Officer/Principal | - |
| KITE PHARMA INC | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PYC THERAPEUTICS LIMITED | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
| Amgen Australia Pty Ltd. |
